Einige Inhalte dieser Anwendung sind momentan nicht verfügbar.
Wenn diese Situation weiterhin besteht, kontaktieren Sie uns bitte unterFeedback&Kontakt
1. (WO2012040223) METHOD FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE-II DIABETES
Anmerkung: Text basiert auf automatischer optischer Zeichenerkennung (OCR). Verwenden Sie bitte aus rechtlichen Gründen die PDF-Version.

1. A HepG2 cell line comprising an enhanced peroxisome targeting fluorescent reporter (EPTFR) that expresses a GFP variant labeling peroxisomes in live cells.

2. The cell line according to claim 1 wherein the EPTFR comprises a carboxy terminal three amino acid peptide Peroxisome Targeting Sequence 1 (PTS1).

3. The cell line according to claim 1 wherein the EPTFR comprises arginine- RSKL.

4. A method for identifying compounds that increase peroxisome biogenesis comprising adding a compound to the cell line of claim 1 and measuring peroxisome biogenesis.

5. An assay comprising the cell line of claim 1 and a means for measuring peroxisome biogenesis.

6. An assay comprising the cell line of claim 1 and a means for measuring cellular peroxisomal mass.